BROCCO, DAVIDE
 Distribuzione geografica
Continente #
NA - Nord America 2.297
EU - Europa 1.402
AS - Asia 1.291
Continente sconosciuto - Info sul continente non disponibili 225
SA - Sud America 203
AF - Africa 35
OC - Oceania 3
Totale 5.456
Nazione #
US - Stati Uniti d'America 2.201
SG - Singapore 630
IT - Italia 584
CN - Cina 252
IE - Irlanda 179
VN - Vietnam 168
BR - Brasile 159
RU - Federazione Russa 129
SE - Svezia 109
DE - Germania 93
GB - Regno Unito 61
CA - Canada 54
FR - Francia 46
HK - Hong Kong 42
IN - India 41
NL - Olanda 41
BD - Bangladesh 40
FI - Finlandia 32
TR - Turchia 27
UA - Ucraina 21
ES - Italia 18
JP - Giappone 17
MX - Messico 17
PL - Polonia 17
AT - Austria 16
IQ - Iraq 16
ZA - Sudafrica 16
AR - Argentina 15
CZ - Repubblica Ceca 14
CO - Colombia 13
LT - Lituania 12
PK - Pakistan 11
BE - Belgio 9
EC - Ecuador 7
ID - Indonesia 7
JM - Giamaica 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 5
TN - Tunisia 5
CR - Costa Rica 4
MA - Marocco 4
MY - Malesia 4
AL - Albania 3
AU - Australia 3
DZ - Algeria 3
EE - Estonia 3
GR - Grecia 3
JO - Giordania 3
KE - Kenya 3
KR - Corea 3
PT - Portogallo 3
PY - Paraguay 3
RO - Romania 3
SA - Arabia Saudita 3
SV - El Salvador 3
BS - Bahamas 2
CH - Svizzera 2
CL - Cile 2
EG - Egitto 2
GT - Guatemala 2
KZ - Kazakistan 2
LB - Libano 2
NP - Nepal 2
TT - Trinidad e Tobago 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
BW - Botswana 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
EU - Europa 1
GD - Grenada 1
GP - Guadalupe 1
HN - Honduras 1
IL - Israele 1
KH - Cambogia 1
KW - Kuwait 1
MT - Malta 1
NI - Nicaragua 1
PE - Perù 1
PH - Filippine 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SC - Seychelles 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TW - Taiwan 1
UY - Uruguay 1
VE - Venezuela 1
Totale 5.233
Città #
Singapore 499
San Jose 300
Ashburn 190
Chandler 180
Dublin 174
Pescara 143
Dallas 92
Chieti 87
Council Bluffs 87
Los Angeles 74
Beijing 68
Santa Clara 62
The Dalles 58
Ho Chi Minh City 54
Jacksonville 49
Munich 46
Princeton 46
Hanoi 45
New York 37
Hong Kong 36
Buffalo 32
Rome 32
Phoenix 27
Amsterdam 25
Altamura 23
Boardman 22
Montreal 20
Ancona 19
Columbus 18
Dong Ket 17
Hefei 17
Izmir 17
Moscow 17
Wilmington 17
Milan 16
Redondo Beach 16
Ascoli Piceno 15
Orem 15
São Paulo 15
Houston 14
Johannesburg 14
Tongling 14
Ann Arbor 13
Frankfurt am Main 13
North Bergen 13
Nuremberg 13
St Louis 13
Washington 13
Atlanta 12
Dearborn 12
Lappeenranta 12
Tokyo 12
Warsaw 12
Brno 11
Denver 11
London 11
Seattle 11
Toronto 11
Vienna 11
Chicago 10
Norwalk 10
Turku 10
Boston 9
Brooklyn 9
Brussels 9
Chennai 9
Helsinki 9
Pune 9
Lanciano 8
League City 8
L’Aquila 8
Nanjing 8
Baghdad 7
Belo Horizonte 7
Charlotte 7
Haiphong 7
Kingston 7
Mexico City 7
Mordano 7
Oklahoma City 7
Rio de Janeiro 7
Bologna 6
City of London 6
Corridonia 6
Da Nang 6
Falls Church 6
Ninh Bình 6
San Francisco 6
Woodbridge 6
Guangzhou 5
Islamabad 5
Kimball 5
New Delhi 5
Ottawa 5
Poplar 5
Santa Fe 5
Tashkent 5
Thái Nguyên 5
Verona 5
Brasília 4
Totale 3.234
Nome #
CD19.CAR-T cell-derived extracellular vesicles express CAR and kill leukemic cells, contributing to antineoplastic therapy 208
Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation 206
Impact of BMI on clinical outcome in advanced cancer patients treated with anti‑PD‑1 Immune checkpoint inhibitors: a preliminary analysis 195
Breast cancer "tailored follow-up" in Italian oncology units: A web-based survey 191
CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy 183
High Blood Concentration of Leukocyte-Derived Extracellular Vesicles Is Predictive of Favorable Clinical Outcomes in Patients with Pancreatic Cancer: Results from a Multicenter Prospective Study 168
Blood Circulating CD133+ Extracellular Vesicles Predict Clinical Outcomes in Patients with Metastatic Colorectal Cancer 166
Exosomes as pleiotropic players in pancreatic cancer 164
Resveratrol Derivative Exhibits Marked Antiproliferative Actions, Affecting Stemness in Pancreatic Cancer Cells 162
Multi-omics staging of locally advanced rectal cancer predicts treatment response: a pilot study 155
Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical Trials 153
Flow Cytometry Detection of Anthracycline-Treated Breast Cancer Cells: An Optimized Protocol 147
Optimizing the Choice for Adjuvant Chemotherapy in Gastric Cancer 143
Exploring the Immunomodulatory Potential of Pancreatic Cancer-Derived Extracellular Vesicles through Proteomic and Functional Analyses 142
Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: a multicenter real-life study 141
Early prediction of resistance to tyrosine kinase inhibitors by plasma monitoring of EGFR mutations in NSCLC: A new algorithm for patient selection and personalized treatment 137
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study 135
FACS-Proteomics strategy toward extracellular vesicles single-phenotype characterization in biological fluids: exploring the role of leukocyte-derived EVs in multiple sclerosis 134
Predictive value of skeletal muscle mass for immunotherapy with nivolumab in non-small cell lung cancer patients: A “hypothesis-generator” preliminary report 129
Corrigendum to "Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation" 128
Drug repurposing, an attractive strategy in pancreatic cancer treatment: Preclinical and clinical updates 127
Tgf-β1 transcriptionally promotes 90K expression: possible implications for cancer progression 126
Multicentric retrospective analysis of platinum-pemetrexed regimens as first-line therapy in non-squamous non-small cell lung cancer patients: A “snapshot” from clinical practice 125
Prognostic value of gender and primary tumor location in metastatic colon cancer 125
Phenotypic and proteomic analysis identifies hallmarks of blood circulating extracellular vesicles in NSCLC responders to immune checkpoint inhibitors 121
Family history of cancer as surrogate predictor for immunotherapy with anti-PD1/PD-L1 agents: preliminary report of the FAMI-L1 study 120
Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians’ attitudes 120
Low Phosphatidylserine+ Cells Within the CD34+/CD45dim/CD117(c-kit)+ Subpopulation Are Associated with Poor Outcomes in Metastatic Colorectal Cancer 116
Screening of Benzimidazole-Based Anthelmintics and Their Enantiomers as Repurposed Drug Candidates in Cancer Therapy 112
The Role of Dysfunctional Adipose Tissue in Pancreatic Cancer: A Molecular Perspective 109
Whole breast radiotherapy in cN0 early breast cancer patients with pathological sentinel lymph nodes (pN1mic, pN1a) without axillary dissection: preliminary results of the observational LISEN trial 102
P1.09 Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation in NSCLC 100
Synthesis and evaluation of a large library of nitroxoline derivatives as pancreatic cancer antiproliferative agents 99
Diagnostic and prognostic roles of endothelial- and platelet-derived extracellular vesicles in cardiovascular diseases 95
Pancytopenia During Osimertinib Treatment in a Patient with EGFR-Mutated Non-Small Cell Lung Cancer 90
High blood concentration of circulating cancer stem cell-derived extracellular vesicles is associated with poor survival in advanced colorectal cancer patients 84
From cachexia to obesity: the role of host metabolism in cancer immunotherapy 83
Novel strategies exploiting interleukin-12 in cancer immunotherapy 83
Intratumoral Gene Transfer of mRNAs Encoding IL12 in Combination with Decoy-Resistant IL18 Improves Local and Systemic Antitumor Immunity 78
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation 78
Deep polychromatic flow cytometry characterization of circulating endothelial cells in metastatic colorectal cancer patients 71
RECIST progression: Patterns among target, non-target, non-measurable and new lesions progression. 22
null 21
Role of Bisphenol A in the Development and Progression of Colorectal Cancer: Possible Sex-Specific Effects of Endogenous and Exogenous Estrogens. 17
Circulating endothelial cells, circulating endothelial progenitors and endothelial extracellular vesicles as new biomarkers in colorectal cancer 12
An optimized flow cytometry method for single extracellular vesicle subtyping, counting, and isolation 9
An optimized flow cytometry method for the analysis of extracellular vesicle from fresh peripheral blood samples 8
The role of circulating endothelial cells and endothelial extracellular vesicles as new biomarkers in colorectal cancer 8
Low phosphatidylserine+ levels and percentages of cells within the CD34+/CD45dim/CD117(c-kit) + subpopulation are associated with poor outcomes in metastatic colorectal cancer 5
null 2
null 1
Totale 5.456
Categoria #
all - tutte 22.729
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.729


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022164 0 0 0 52 2 25 12 8 11 3 12 39
2022/2023578 38 70 77 52 38 93 29 76 58 5 17 25
2023/2024423 35 5 25 32 10 132 64 16 11 17 7 69
2024/20251.162 39 171 177 53 24 54 151 67 97 80 108 141
2025/20262.208 208 93 191 220 226 116 363 146 242 193 135 75
2026/2027565 32 107 178 248 0 0 0 0 0 0 0 0
Totale 5.456